LES BRÈVES DE L'ACTUALITÉ | 28 FÉVRIER 2022

Sur le même sujet

• 

  25 septembre 2020

  Appel à projets : IA pour les chaînes d'approvisionnement | Call for Projects: AI for Supply Chains

  Pour visualiser ce message dans votre navigateur, cliquez ici Appel à projets du CEIM 24/09/2020 Nouveaux programmes subventionnés pour accélérer votre démarrage et la commercialisation de votre innovation Dans le cadre d'une nouvelle entente avec Scale AI (la supergrappe d'intelligence artificielle canadienne), le CEIM est fier d'annoncer le lancement de deux nouveaux programmes d'incubation et d'accélération. Ceux-ci s'adressent aux jeunes startups ayant développé une solution d'IA appliquée aux chaînes d'approvisionnement et pourraient s'accompagner d'une aide financière pouvant aller jusqu'à 35 000 $ par projet. Pour être admissibles, les entreprises doivent : avoir leur siège social au Québec présenter un projet innovant à fort potentiel de croissance et d'exportation être en opération depuis moins de 2 ans, avec peu ou pas de revenu pour bénéficier des services d'incubation ou être en opération depuis moins de 5 ans, avec des revenus annuels de 500 000 à 5 M$ pour bénéficier des services d'accélération Des services de consultation sur mesure, adaptés en fonction de vos besoins spécifiques Startups en démarrage Startups en phase de commercialisation Validation du potentiel commercial/proposition de valeur Stratégie de mise en marché/positionnement Plan d'affaires, planification stratégique et financière Stratégie P.I, encadrement juridique et crédits d'impôt RS&DE Revue du plan marketing Diagnostic commercial/potentiel à l'exportation Acquisition de clients/développement de marché Processus d'embauche d'un(e) représentant(e) aux ventes Développement des affaires POUR PLUS D'INFORMATION ET SOUMETTRE VOTRE DEMANDE Les projets seront sélectionnés en continu, en collaboration avec Scale AI, mais le nombre de dossiers retenus est limité. Les entreprises intéressées sont donc invitées à prendre contact avec nous et à soumettre leur candidature sans tarder. Pour plus d'information, prière de contacter Serge Bourassa (sbourassa@ceim.org). ⇨ Téléchargez le formulaire de candidature New subsidized programs to accelerate your startup and the commercialization of your innovation As part of a new partnership agreement with Scale AI (Canada's Artificial Intelligence Supercluster), CEIM is proud to announce the launch of two new incubation and acceleration programs. These are aimed at young startups that have developed an AI solution applied to supply chains and could be accompanied by financial support of up to $ 35,000 per project. To be eligible, companies must: have their head office in Quebec present an innovative project with high growth and export potential be in operation for less than 2 years, with little or no income to take advantage of our incubation services or be in operation for less than 5 years, with annual revenues of $ 500,000 to $ 5 Million to take advantage of our acceleration services Customized consulting services that are tailored to your specific needs Early-stage startups Growth-stage startups Evaluation of market potential/value proposition Go-to-market strategy/positioning Business, strategic and financial planning I.P strategy, legal counsel, R&D tax credits Marketing plan review Commercial diagnostic/export potential Customer acquisition/market development Hiring of a sales representative Business development FOR MORE INFORMATION AND TO SUBMIT YOUR APPLICATION The projects will be selected, in collaboration with Scale AI, on a continuous basis but the number of shortlisted applications is limited. Interested companies are therefore encouraged to contact us and submit their application without delay. For more information, please contact Serge Bourassa (sbourassa@ceim.org). ⇨ Download the application form Follow us on social networks! You are receiving this email because you opted-in your email address sbourassa@ceim.org to receive updates from us. Add in your contacts list to ensure that you receive our emails in your inbox. To unsubscribe or manage your email preferences, click here. CEIM | 33, rue Prince | Montreal, QC H3C 2M7 Canada Copyright © 2020 CEIM

• 

  4 novembre 2021

  Appel à dépôt de projets - Cohorte Hiver 2022 | Programme Accélération Centech

  Ouverture des candidatures pour le programme Accélération Cohorte Hiver 2022 en format hybride le mardi 26 octobre à 09h00 Incubateur de calibre mondial, le Centech accompagne les entreprises de haute technologie à fort potentiel. Le Centech est ouvert à tous et se distingue notamment dans les domaines des technologies médicales, du manufacturier, des télécoms et microélectronique et autres objets intelligents. Si vous désirez : - valider le potentiel commercial de votre innovation technologique - préciser le produit à mettre sur le marché - établir le modèle d'affaires - présenter votre projet aux investisseurs Gratuit et entièrement bilingue, le programme Accélération du #Centech est fait pour vous ! Ce programme intensif et structuré de 12 semaines vous offrira la possibilité de bénéficier d'un coaching par les entrepreneurs en résidence, d'ateliers offerts par des partenaires et experts reconnus, des témoignages d'entrepreneurs à succès, l'accès à des locaux de qualité, l'opportunité de participer à de nombreux événements. Les inscriptions à la cohorte #Accélération Hiver 2022 sont maintenant ouvertes ! Vous pensez avoir l''me d'un Accéléré ? Soumettez dès maintenant votre candidature via les liens ci-dessous et surtout lisez bien les instructions ! FR : https://centech.co/depot-de-candidatures EN : http://centech.co/en/applications Date limite : mercredi 12 janvier 2022 @ 17h00 HNE.

• 

  27 mars 2020

  NRC COVID-19 response

  The Government of Canada is taking strong and quick action to protect our economy, and the health and safety of all Canadians during this global outbreak of the novel coronavirus (COVID-19). We are working with our partners as part of the collective effort to help find solutions to the COVID-19 outbreak: 1. The COVID-19 Challenges Procurement Program: NRC Industrial Research Assistance Program and Innovative Solutions Canada Purpose: This program will post challenges seeking near-to-market solutions from small and medium-sized businesses (fewer than 500 staff) that need financial support from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to refine and sell their product or solution to meet a COVID-19 related need. NRC IRAP works with roughly 8,000 small and medium-sized businesses every year through its cross-Canada network of 255 industrial technology advisors and provides over $300 million in support to more than 3,000 technology development projects annually Through this initiative, the Public Health Agency of Canada (PHAC) and Health Canada (HC) will establish a number of challenges corresponding to needs of health providers to deal with COVID-19 NRC IRAP will partner with Innovative Solutions Canada to launch calls for proposals over the next few weeks to address challenges, fund development of solutions, and buy successful products and services needed to address COVID-19 Together, NRC IRAP and Innovative Solutions Canada will: post the PHAC and HC challenges (Innovative Solutions Canada) award Phase 1 funding to successful small and medium-sized businesses to develop a proof of concept for their solution (NRC IRAP) award Phase 2 funding to the firms with the best concepts so they can develop a working prototype (NRC IRAP) The NRC, PHAC, HC or another federal department or agency will then be able purchase the product for use against COVID-19. Innovative Solutions Canada already has challenges in development, which they will begin posting to their website in the coming days. These will continue as PHAC, HC, and health care providers request new topics. Companies with promising technology relevant to the COVID-19 challenges can register their technology or product by clicking on the Register button below. Register 2. The Pandemic Response Challenge Program: National Research Council of Canada Purpose: This program will build teams to address challenges requiring further research and development for solutions to meet COVID-19 related needs. The NRC will build these teams drawing on internal-to-government capacity and academic researchers who register using the button below to indicate their interest, and related areas of expertise and capabilities. The NRC will receive $15M to form dedicated teams to address challenges in the areas of greatest research and development (R&D) need in the fight against COVID-19. The NRC Pandemic Response Challenge Program will accelerate the development of diagnostics and medical countermeasures for a rapid front-line response to protect and treat Canadians. This national vehicle will convene the best Canadian and international researchers from academia and small and medium-sized businesses to collectively accelerate R&D to address specific COVID-19 gaps and challenges as identified by Canadian health experts. The Pandemic Response Challenge Program is currently structured around 3 main research areas: Rapid detection and diagnosis Therapeutics and vaccine development and Digital health. Researchers at Canadian and international universities, government departments, colleges, and highly innovative firms with relevant expertise can now register their interest to work with us on these challenges by clicking the Register button below. Funding is available to help cover the costs of research for academic institutions, small and medium-sized businesses, and other eligible recipients participating in the challenge teams. Over the coming weeks, we will post the specific R&D challenges, send information to registered researchers, and invite them to indicate the expertise and capabilities they can bring to a team. Register 3. Biomanufacturing capacity at Royalmount: NRC Human Health Therapeutics Research Centre Purpose: This initiative will result in a Good Manufacturing Practices platform to develop and scale up COVID-19 Canadian vaccine and therapy candidates. The NRC Biomanufacturing facility, located in the NRC's Royalmount Avenue building in Montréal, is used to develop and scale up processes to produce biological medicines and is managed by the Human Health Therapeutics Research Centre. As part of its development capacity, the facility is equipped with pilot-scale bioreactors (200 L and 500 L), which will be operationally available to produce up to 100,000 doses of vaccine per month within 6 months once a vaccine suitable for front-line responders is available. A $15 million investment will fund the certification of the facility for Good Manufacturing Practices compliance, and will enable production of material that will be used in humans, particularly for vaccines or therapeutics. This certification can also greatly increase the capacity for candidate vaccines or therapeutics to be quickly rolled out and clinically tested, particularly those originating from Canada. The work to refine and certify quality systems at the facility will include: bringing the existing facility to regulatory standards, installing equipment to expand capacity, and managing information. Once certified, this facility will be able to accelerate the scale-up production and testing of various types of vaccine candidates in the context of the current COVID-19 outbreak, including protein-based, viral vector-based, and antibody-based products. https://nrc.canada.ca/en/research-development/research-collaboration/nrc-covid-19-response